| ★ | Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD | | 198 | Estados Unidos | |
| 9 | Inhaled Treprostinil for IPF: TETON-1 Phase 3 Results With Steven Nathan, MD | ATS 2026 | | 301 | Estados Unidos | 63 |
| 13 | Why Fewer Than Half of Referred Patients Reach Kidney Transplant Evaluation | | 217 | Estados Unidos | 62 |
| 11 | New Martin-Hopkins LDL-C-Estimating Equation Simplifies Implementation for Comparable Results | | 151 | Estados Unidos | 63 |
| 16 | FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD | | 131 | Estados Unidos | 62 |
| 1 | AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD | | 105 | Estados Unidos | 82 |
| 17 | What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis? | | 92 | Estados Unidos | 62 |
| 2 | Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD | | 88 | Estados Unidos | 67 |
| 8 | SYMPHONY-PE: Early Thrombectomy Improves Pulmonary Embolism Outcomes | | 86 | Estados Unidos | 64 |
| 15 | SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma | | 78 | Estados Unidos | 62 |
| 19 | Dupilumab Doubled Asthma Remission Odds in Type 2 Asthma: | | 71 | Estados Unidos | 61 |
| 7 | Omalizumab vs Oral Immunotherapy for Multifood Allergy | | 65 | Estados Unidos | 64 |
| 5 | ADorable-1 Results: Key Findings in Pediatric Atopic Dermatitis | | 58 | Estados Unidos | 65 |
| 3 | Lifestyle, Pharmacologic Therapies, and EXCEL Trial Data Reshape MASLD Treatment Framework | | 48 | Estados Unidos | 66 |
| 12 | Optimizing IBD Treatment and Sequencing, With Jordan Axelrad, MD, MPH | | 46 | Estados Unidos | 62 |
| 18 | What is the Link Between Atopic Dermatitis and Asthma? With Eingun James Song, MD | | 40 | Estados Unidos | 62 |
| 4 | FMD Peak Systolic Velocity May Lead to Comprehensive Clinical Guidelines | | 33 | Estados Unidos | 65 |
| 6 | Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026 | | 31 | Estados Unidos | 65 |
| 10 | Abdominal Pain and Bloating: Recognizing HAE, MCAS, and Eosinophilic GI Disorders | Brian Lacy, MD | | 20 | Estados Unidos | 63 |
| 14 | Time to Minimum Residual C-Peptide As a Predictor of Treatment Efficacy in T1D | | 16 | Estados Unidos | 62 |
| 20 | What is the Role of Immunology in Atopic Dermatitis Care? With Jay Lieberman, MD | | 13 | Estados Unidos | 61 |